查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1997404

外科影像市场：按组件、技术、模式、便携性和安装、影像解析度和格式、临床应用以及最终用户划分－2026-2032年全球市场预测

Surgical Imaging Market by Component, Technology, Modality, Mobility & Installation, Imaging Resolution & Format, Clinical Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，外科影像市场价值将达到 42 亿美元，到 2026 年将成长至 49.1 亿美元，到 2032 年将达到 132.4 亿美元，年复合成长率为 17.82%。

主要市场统计数据
基准年 2025 42亿美元
预计年份：2026年 49.1亿美元
预测年份 2032 132.4亿美元
复合年增长率 (%) 17.82%

临床重点和技术进步的融合正在将外科成像转变为一种策略要素，从而实现卓越的技术和营运韧性。

手术影像正在重塑临床医生术中决策的方式，它融合了先进的视觉化技术、手术效率和以病人为中心的护理理念。在当今的外科手术环境中，人们越来越依赖高解析度影像来降低手术不确定性，实现更精准的切除、标靶介入并改善治疗效果。随着数位架构和微型化成像技术的进步，手术团队正在采用整合式视觉化平台，这些平台结合了即时成像和导航、扩增实境（AR）迭加以及简化的资料管理。

外科影像领域的主要结构性变化是由模态整合、软体定义能力和价值驱动的筹资策略所驱动的。

过去几年，外科影像领域经历了翻天覆地的变化，这不仅体现在设备的逐步升级上，也体现在医疗服务提供和组织方式的系统性变革。其中一项根本性变革是从单一模态工具向多重模式生态系统的转变，该系统融合了二维透视、断层合成、CT3D重建和基于磁振造影的术中导航。这种整合提高了空间感知能力，并有助于临床环境中复杂的决策。

关税压力的变化如何影响整个外科影像供应链的筹资策略、製造地和供应商选择？

美国关税情势为采购、供应链规划和供应商选择带来了新的考量因素，影响整个外科影像生态系统的仪器定价和筹资策略。关税正在影响区域製造地地点的决策，一些供应商正在重新审视生产基地和供应商合同，以降低成本风险。为此，许多机构正在探索双重采购策略、近岸外包方案以及包含价格稳定条款和库存缓衝的长期供应商合同，以确保临床服务的连续性。

透过协调影像技术、临床应用和终端用户环境的实用分割智能，加速采用和临床整合。

了解市场区隔趋势对于使产品开发和市场进入策略与实际临床需求保持一致至关重要。在将技术分为二维和3D成像时，二维成像包括立体定位成像和断层合成等技术，这些技术仍然广泛应用于高频手术，因为在这些手术中，快速可视化和最小的面积占用空间至关重要。相较之下，3D成像又细分为基于CT和基于MR的三维繫统，它们着重于容积重建和软组织对比度，用于复杂的手术规划和术中导航。

本文探讨了全球外科影像市场中决定商业性机会的采用路径、监管反应以及区域趋势和基础设施差异。

区域趋势对外科影像生态系中的技术采纳、监管路径和经营模式有显着影响。在美洲，医疗系统对能够提升手术效率并支援一次性支付模式的整合解决方案表现出浓厚的兴趣，而北美医疗机构则往往优先考虑互通性、临床证据和供应商的快速支援。在美洲部分地区，监管的明确性和完善的报销机制正在加速新型术中影像应用的早期临床部署，但由于需要获得众多相关人员的核准，采购週期可能会延长。

竞争格局分析揭示了平台模组化、软体差异化和卓越服务如何推动供应商定位和伙伴关係。

外科影像中心的竞争格局由成熟的医疗设备製造商、专业软体供应商和专注于特定临床应用的新兴技术公司共同构成。成熟的系统供应商持续投资于模组化平台，使医疗机构能够在多个手术室扩展功能，同时利用现有服务网路确保运转率和可预测的生命週期成本。同时，专业软体公司凭藉先进的影像处理、导航演算法和分析功能脱颖而出，从影像资料集中挖掘更多临床价值。

为协调采购、互通性、商业化和临床医生采纳，创造由影像主导的永续价值，提出切实可行的策略建议。

产业领导企业应采取谨慎的态度，平衡短期营运重点与基于影像的临床流程的长期策略投资。首先，应透过定义与影像投资相关的可衡量绩效指标（例如降低再次手术率和提高术中决策的信心），使采购惯例与临床结果目标保持一致。将采购决策与明确的临床和财务指标挂钩，有助于证明资本分配的合理性，并促进外科、放射科和财务等相关人员之间达成跨职能共识。

结合对临床医生的访谈、对临床文献的回顾和交叉检验的多方面研究途径，将得出基于证据的策略见解。

本执行摘要的研究结合了多种定性和定量方法，以确保获得全面而深入的见解。主要研究包括对来自不同类型和地区的医院的临床负责人、生物医学工程师、采购主管和产品经理进行结构化访谈。这些访谈聚焦于术中影像实施过程中的临床工作流程、采购标准和优先事项，从而提供了关于营运限制和决策因素的第一手观点。

证据与策略的整合表明，协作实施影像驱动的工作流程可以持续改善病患预后和营运绩效。

手术影像技术正从单纯的辅助技术发展成为现代外科医疗服务的核心要素，对临床结果、工作流程设计和供应商生态系统都产生深远的影响。多模态影像、先进软体和整合工作流程的融合，为减少手术差异、提高手术精准度以及实现数据驱动的改进循环创造了机会。同时，务实的筹资策略和灵活的商业性安排对于应对因关税趋势而更加复杂的采购和供应链挑战至关重要。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 外科影像市场：依组件划分

  • 配件和耗材
    • 造影剂/染料（ICG）
    • 窗帘罩
  • 硬体
    • 电缆和连接设备
    • 相机镜头镜
    • 检测器和感测器
    • 显示录影机
    • 影像系统
    • 光源
  • 服务
    • 安装与检验
    • 维护/修理
    • 託管服务
    • 培训和教育
  • 软体
    • 三维重建
    • 人工智慧应用
    • 剂量管理
    • 影像处理
    • 工作流程和PACS集成

第九章 外科影像市场：依技术划分

  • 二维成像
    • 立体定位成像
    • 断层合成
  • 三维成像
    • 基于CT的3D
    • 基于磁振造影的3D

第十章 外科影像市场：依影像方式划分

  • 内视镜成像
  • 磁振造影
  • 光学和分子成像
    • 近红外线(NIR) / ICG萤光
    • 光学同调断层扫描
  • 手术显微镜
  • 超音波
  • X射线和透视
    • 固定式C臂/血管造影术
      • 吸顶式系统
      • 混合手术室系统
    • 术中CT/O臂
    • 移动式C臂
      • 全尺寸C型臂
      • 迷你C型臂

第十一章 依移动性和安装方式分類的外科影像市场

  • 固定的
    • 吸顶式
    • 落地式
  • 活动
    • 购物车类型
  • 可移动龙门架/滑动磁铁

第十二章 按影像解析度和格式分類的外科影像市场

  • 4K
  • 8K
  • 颜色
  • 可见光/近红外线双通道
  • HD 1080p
  • 黑白

第十三章：依临床应用分類的外科影像市场

  • 循环系统
    • 血管内
    • 结构性心臟疾病
  • 耳鼻喉科/头颈外科
    • 鼻窦
    • 颅底
  • 一般外科
    • 大肠和直肠
    • 肝胆胰
  • 神经外科
    • 功能性/DBS
    • 肿瘤切除
  • 整形外科/创伤
    • 骨折固定
    • 脊椎手术
  • 泌尿系统和妇科
    • 子宫切除术
    • 摄护腺

第十四章 外科影像市场：依最终使用者划分

  • 门诊手术中心
  • 医院
    • 大学医院
    • 当地医院
  • 专科诊所及内部检查室

第十五章 外科影像市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 外科影像市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 外科影像市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国外科影像市场

第十九章：中国外科影像市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Canon Medical Systems Corporation
  • Carl Zeiss Meditec AG
  • CONMED Corporation
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • KARL STORZ SE & Co. KG
  • Koninklijke Philips NV
  • Leica Microsystems GmbH
  • Medtronic plc
  • Mindray Medical International Limited
  • Olympus Corporation
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • Stryker Corporation
Product Code: MRR-501246437219

The Surgical Imaging Market was valued at USD 4.20 billion in 2025 and is projected to grow to USD 4.91 billion in 2026, with a CAGR of 17.82%, reaching USD 13.24 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.20 billion
Estimated Year [2026] USD 4.91 billion
Forecast Year [2032] USD 13.24 billion
CAGR (%) 17.82%

How converging clinical priorities and technological advances are transforming surgical imaging into a strategic enabler of procedural excellence and operational resilience

Surgical imaging is at the confluence of advanced visualization, procedural efficiency, and patient-centered care, reshaping how clinicians approach intraoperative decision-making. Modern operating environments increasingly rely on high-fidelity imaging to reduce uncertainty during procedures, enabling more precise resections, targeted interventions, and improved outcomes. As digital architectures and miniaturized imaging technologies advance, surgical teams are adopting integrated visualization platforms that combine real-time imaging with navigation, augmented reality overlays, and streamlined data management.

Clinicians and hospital leaders now seek solutions that deliver both clinical clarity and operational value. Consequently, vendors prioritize interoperable architectures and user-centered interfaces that minimize workflow friction in high-acuity settings. The resulting shift is not merely technological; it is organizational. Cross-disciplinary teams, including surgical specialties, radiology, biomedical engineering, and IT, must align around shared performance metrics and governance for imaging-driven procedures. This transformation favors systems that balance image quality, ease of use, and seamless integration with electronic health records and perioperative information systems.

Looking ahead, the emphasis on reproducible outcomes and evidence-based procedure standardization will drive deeper collaboration between manufacturers and health systems. Investment decisions will hinge on the ability of imaging solutions to demonstrably reduce variability in procedural performance while supporting adoption through training, service, and analytics capabilities. In short, surgical imaging is evolving from an ancillary tool to a strategic enabler of procedural excellence and operational resilience.

Major structural changes in surgical imaging driven by modality convergence, software-defined capabilities, and value-oriented procurement strategies

Over the past several years, the surgical imaging landscape has experienced transformative shifts that extend beyond incremental device upgrades to systemic changes in how care is delivered and organized. One fundamental shift is the migration from single-modality tools toward multi-modal ecosystems that combine 2D fluoroscopy, tomosynthesis, CT-derived three-dimensional reconstructions, and MR-based intraoperative guidance. This amalgamation enhances spatial understanding and supports complex decision-making at the point of care.

Parallel to modality convergence is the rise of software-defined imaging. Artificial intelligence and advanced image-processing algorithms now play a central role in enhancing contrast, reducing noise, and automating routine measurements. Consequently, imaging vendors compete not only on hardware fidelity but on software capabilities that improve throughput and diagnostic confidence. Additionally, seamless connectivity and standardized data exchange protocols have catalyzed integration between imaging suites and the broader hospital infrastructure, enabling synchronized intraoperative workflows and retrospective outcome analytics.

Economic and regulatory forces have also reshaped procurement behaviors. Health systems emphasize total cost of ownership, uptime guarantees, and service models that prioritize rapid deployment and predictable maintenance. Simultaneously, clinical stakeholders demand evidence of clinical utility and value-measured through reductions in complication rates, shorter procedure times, or improved functional outcomes. Taken together, these shifts compel providers and suppliers to reorient strategies around collaborative, data-rich partnerships that accelerate adoption and scale the clinical benefits of advanced surgical imaging.

How evolving tariff pressures are reshaping procurement strategies, manufacturing footprints, and vendor selection across surgical imaging supply chains

The tariff landscape in the United States has introduced additional considerations for procurement, supply-chain planning, and vendor selection, affecting device pricing and sourcing strategies across the surgical imaging ecosystem. Tariffs influence decisions around regional manufacturing footprints, with some suppliers reassessing production locations and supplier contracts to mitigate cost exposure. In response, several organizations are exploring dual-sourcing strategies, nearshoring options, and longer-term supplier contracts that include price stabilization clauses and inventory buffering to preserve continuity of clinical services.

Operational teams and purchasing departments increasingly incorporate tariff scenarios into procurement timelines, evaluating the trade-offs between acquiring immediately available inventory versus waiting for products that can be sourced under more favorable customs conditions. As a result, procurement windows have lengthened for certain classes of imaging equipment, and capital planning cycles now more frequently include contingency allowances for import duty variability. These dynamics also incentivize vendors to offer flexible commercial terms that transfer some tariff-related risk away from the provider, such as price protection guarantees or deferred delivery agreements.

From a strategic perspective, the tariff environment accelerates vendor consolidation and local partnership models. Suppliers with established domestic manufacturing or robust localized service networks gain distinct competitive advantages because they can minimize exposure to cross-border tariff volatility while offering faster deployment and lower lifecycle logistics costs. In the near term, stakeholders should anticipate ongoing adjustments to contractual frameworks, logistics strategies, and vendor due diligence practices as organizations seek to balance cost, access, and operational certainty in a tariff-influenced environment.

Actionable segmentation intelligence that aligns imaging technologies, clinical applications, and end-user environments to accelerate adoption and clinical integration

Understanding segmentation dynamics is critical to aligning product development and go-to-market strategies with real-world clinical needs. When technologies are parsed into two-dimensional imaging and three-dimensional imaging, the two-dimensional category includes stereotactic imaging and tomosynthesis modalities that continue to serve high-volume procedures where rapid visualization and minimal footprint are paramount. In contrast, three-dimensional imaging subdivides into CT-based 3D systems and MR-based 3D systems that emphasize volumetric reconstruction and soft-tissue contrast for complex surgical planning and intraoperative guidance.

Applications shape clinical value propositions across cardiovascular, gastrointestinal, neurological, orthopedic, and urological procedures. Cardiovascular interventions prioritize high temporal resolution and precise vessel visualization to support catheter-based therapies, while gastrointestinal and urological procedures often call for compact, flexible imaging that fits within endoscopy suites. Neurological use cases demand exceptional spatial accuracy and brain-tissue contrast for resection guidance and functional preservation. Orthopedic implementations focus on bone detail and intraoperative alignment to optimize implant positioning and minimize revision rates. Tailoring product features to these differentiated clinical requirements increases adoption likelihood and reinforces clinical partnership.

End-user segmentation further refines deployment strategies, distinguishing ambulatory surgical centers, diagnostic centers, and hospitals as distinct adoption environments. Ambulatory surgical centers encompass both freestanding centers and hospital-associated centers that emphasize throughput and narrow procedural scopes. Diagnostic centers include cancer centers and imaging centers where preoperative planning, lesion localization, and biopsy guidance are primary use cases. Hospitals split into private and public institutions that balance broader procedural portfolios, complex case mixes, and centralized procurement processes. Recognizing these distinctions enables providers and vendors to match solution form factors, service models, and pricing structures to the operational realities and decision-making pathways of each customer type.

Regional dynamics and infrastructure variance that determine adoption pathways, regulatory readiness, and commercial opportunity across global surgical imaging markets

Regional dynamics exert a strong influence on technology adoption, regulatory pathways, and commercial models within the surgical imaging ecosystem. In the Americas, health systems exhibit a strong appetite for integrated solutions that demonstrate procedural efficiency and support bundled payment models, with North American centers often prioritizing interoperability, clinical evidence, and rapid vendor support networks. Regulatory clarity and established reimbursement pathways in portions of the region facilitate earlier clinical introduction for novel intraoperative imaging applications, although procurement cycles can remain elongated due to multi-stakeholder approvals.

In Europe, the Middle East & Africa, regulatory diversity and heterogeneity in healthcare infrastructure lead to differentiated adoption patterns. Western European centers frequently adopt advanced imaging modalities quickly when supported by clear health-technology assessments and clinical guideline endorsements, while other parts of the region require solutions that emphasize cost-effectiveness and adaptable service models. In the Middle East and parts of Africa, investment in tertiary centers and referral hospitals drives interest in high-end imaging platforms for specialized procedures, but broader system-level capacity constraints can slow diffusion.

Across the Asia-Pacific region, rapid infrastructure investment, expanding private hospital networks, and increasing emphasis on surgical subspecialization create fertile conditions for imaging innovation. Countries with strong medical-device ecosystems show accelerated uptake of hybrid operating rooms and image-guided surgery suites, whereas emerging markets prioritize compact and cost-effective solutions that fit constrained capital budgets. Moreover, the Asia-Pacific region is becoming an important manufacturing and R&D base for vendors looking to optimize cost structures and shorten supply chains, which in turn impacts global deployment timelines and commercial partnerships.

Competitive landscape analysis revealing how platform modularity, software differentiation, and service excellence drive vendor positioning and partnerships

Competitive dynamics in surgical imaging center on a mix of established device manufacturers, specialized software vendors, and emerging technology entrants that focus on niche clinical applications. Established system providers continue to invest in modular platforms that allow providers to scale functionality across multiple operating rooms while leveraging existing service networks to ensure uptime and predictable lifecycle costs. At the same time, specialist software firms are differentiating through advanced image processing, navigation algorithms, and analytics that extract incremental clinical value from imaging datasets.

Strategic alliances, targeted acquisitions, and co-development partnerships characterize current activity as vendors seek to pair hardware excellence with software intelligence and clinical workflow expertise. These collaborations often prioritize integration with electronic medical records, cloud-based analytics, and surgical planning tools to deliver seamless end-to-end workflows. Additionally, suppliers are experimenting with subscription and outcome-based contracting models that align vendor compensation with clinical performance, offering providers alternative ways to access advanced imaging capabilities without large upfront capital expenditure.

Service excellence remains a competitive differentiator. Vendors that offer comprehensive training, rapid field service, and proactive parts management secure stronger adoption and higher lifetime value. Meanwhile, newer entrants that bring disruptive capabilities-such as AI-driven tissue characterization or compact intraoperative MR solutions-must prioritize rigorous clinical validation and post-deployment support to gain the trust of surgical teams and procurement committees.

Practical strategic recommendations designed to align procurement, interoperability, commercialization, and clinician adoption for sustained imaging-driven value

Industry leaders should adopt a deliberate approach that balances near-term operational priorities with longer-term strategic investments in imaging-enabled care pathways. First, align procurement practices with clinical outcome objectives by defining measurable performance indicators tied to imaging investments, such as reductions in reoperation rates or improvements in intraoperative decision confidence. Linking purchasing decisions to clear clinical and financial metrics helps justify capital allocation and supports cross-functional buy-in across surgical, radiology, and finance stakeholders.

Second, prioritize interoperability and open standards when evaluating new systems. Solutions that support standardized data exchange and integrate with navigation, electronic records, and analytics platforms reduce implementation friction and future-proof investments against evolving digital architectures. Third, consider flexible commercial models that mitigate tariff and supply-chain risks, including options for localized maintenance agreements, extended warranties, and phased deployments that spread capital exposure while delivering incremental clinical capability.

Fourth, invest in clinician adoption through structured training programs, simulation-based onboarding, and multidisciplinary governance that embeds imaging into clinical protocols. Effective change management accelerates utilization and maximizes return on technology investments. Finally, cultivate innovation partnerships with academic centers and technology firms to pilot advanced applications-such as AI-assisted tissue delineation or augmented-reality overlays-under controlled study conditions that generate evidence for scaled adoption.

A multi-method research approach that integrates clinician interviews, clinical literature review, and cross-validation to produce evidence-grounded strategic insights

The research underpinning this executive summary combined multiple qualitative and quantitative approaches to ensure robust, multi-perspective insights. Primary research included structured interviews with clinical leaders, biomedical engineers, procurement executives, and product managers across diverse hospital types and geographic regions. These conversations focused on clinical workflows, procurement criteria, and priorities for intraoperative imaging adoption, providing firsthand perspectives on operational constraints and decision drivers.

Secondary research involved systematic review of peer-reviewed clinical studies, regulatory filings, product brochures, and public company disclosures to validate clinical claims, technological capabilities, and commercial strategies. The analytical framework integrated technology assessment with application mapping and end-user segmentation to generate actionable insights. Across stages, findings were triangulated through cross-validation workshops with subject-matter experts to reconcile conflicting inputs and test hypothesis sensitivity.

Limitations include variation in regional regulatory environments and heterogeneity in reporting standards across institutions, which the methodology accounted for through stratified sampling and sensitivity analyses. Where appropriate, assumptions were explicitly documented and expert consensus was used to interpret ambiguous or proprietary data. This mixed-methods approach yields a balanced, evidence-grounded perspective designed to inform operational decisions and strategic planning for stakeholders in surgical imaging.

Synthesis of evidence and strategy showing how collaborative adoption of imaging-enabled workflows can sustainably improve patient outcomes and operational performance

Surgical imaging is transitioning from a supporting technology to a central component of modern surgical care delivery, with implications for clinical outcomes, workflow design, and supplier ecosystems. The convergence of multi-modal imaging, advanced software, and connected workflows creates opportunities to reduce procedural variability, enhance surgical precision, and enable data-driven improvement cycles. At the same time, procurement and supply-chain complexities-heightened by tariff dynamics-require pragmatic sourcing strategies and flexible commercial arrangements.

Organizations that proactively align clinical goals with procurement and vendor partnerships stand to realize the greatest benefit. Emphasizing interoperability, rigorous clinical validation, and comprehensive service models will accelerate adoption and embed imaging within standardized care pathways. Meanwhile, vendors that marry hardware performance with software intelligence and dependable service will maintain competitive advantage.

Ultimately, the path forward rests on collaboration: between surgeons, radiologists, biomedical teams, and industry partners to operationalize imaging capabilities in ways that measurably improve patient care and institutional performance. By prioritizing evidence, interoperability, and clinician-centered design, stakeholders can navigate current headwinds and harness surgical imaging as a durable source of clinical differentiation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Imaging Market, by Component

  • 8.1. Accessories & Consumables
    • 8.1.1. Contrast Agents & Dyes (ICG)
    • 8.1.2. Drapes & Covers
  • 8.2. Hardware
    • 8.2.1. Cables & Connectivity
    • 8.2.2. Camera Heads & Scopes
    • 8.2.3. Detectors & Sensors
    • 8.2.4. Displays & Recorders
    • 8.2.5. Imaging Systems
    • 8.2.6. Light Sources
  • 8.3. Services
    • 8.3.1. Installation & Validation
    • 8.3.2. Maintenance & Repair
    • 8.3.3. Managed Services
    • 8.3.4. Training & Education
  • 8.4. Software
    • 8.4.1. 3D Reconstruction
    • 8.4.2. AI Applications
    • 8.4.3. Dose Management
    • 8.4.4. Image Processing
    • 8.4.5. Workflow & PACS Integration

9. Surgical Imaging Market, by Technology

  • 9.1. 2D Imaging
    • 9.1.1. Stereotactic Imaging
    • 9.1.2. Tomosynthesis
  • 9.2. 3D Imaging
    • 9.2.1. Ct-Based 3D
    • 9.2.2. Mr-Based 3D

10. Surgical Imaging Market, by Modality

  • 10.1. Endoscopic Imaging
  • 10.2. Magnetic Resonance
  • 10.3. Optical & Molecular Imaging
    • 10.3.1. NIR/ICG Fluorescence
    • 10.3.2. Optical Coherence Tomography
  • 10.4. Surgical Microscopy
  • 10.5. Ultrasound
  • 10.6. X-Ray & Fluoroscopy
    • 10.6.1. Fixed C-Arm/Angiography
      • 10.6.1.1. Ceiling-Mounted System
      • 10.6.1.2. Hybrid OR System
    • 10.6.2. Intraoperative CT/O-Arm
    • 10.6.3. Mobile C-Arm
      • 10.6.3.1. Full-Size C-Arm
      • 10.6.3.2. Mini C-Arm

11. Surgical Imaging Market, by Mobility & Installation

  • 11.1. Fixed
    • 11.1.1. Ceiling-Mounted
    • 11.1.2. Floor-Mounted
  • 11.2. Mobile
    • 11.2.1. Cart-Based
  • 11.3. Movable Gantry/Sliding Magnet

12. Surgical Imaging Market, by Imaging Resolution & Format

  • 12.1. 4K
  • 12.2. 8K
  • 12.3. Color
  • 12.4. Dual-Channel Visible/NIR
  • 12.5. HD 1080p
  • 12.6. Monochrome

13. Surgical Imaging Market, by Clinical Application

  • 13.1. Cardiovascular
    • 13.1.1. Endovascular
    • 13.1.2. Structural Heart
  • 13.2. ENT/Head & Neck
    • 13.2.1. Sinus
    • 13.2.2. Skull Base
  • 13.3. General Surgery
    • 13.3.1. Colorectal
    • 13.3.2. Hepatobiliary
  • 13.4. Neurosurgery
    • 13.4.1. Functional/DBS
    • 13.4.2. Tumor Resection
  • 13.5. Orthopedic & Trauma
    • 13.5.1. Fracture Fixation
    • 13.5.2. Spine Surgery
  • 13.6. Urology & Gynecology
    • 13.6.1. Hysterectomy
    • 13.6.2. Prostate

14. Surgical Imaging Market, by End User

  • 14.1. Ambulatory Surgical Centers
  • 14.2. Hospitals
    • 14.2.1. Academic Medical Centers
    • 14.2.2. Community Hospitals
  • 14.3. Specialty Clinics & Office-Based Labs

15. Surgical Imaging Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Surgical Imaging Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Surgical Imaging Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Surgical Imaging Market

19. China Surgical Imaging Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Canon Medical Systems Corporation
  • 20.6. Carl Zeiss Meditec AG
  • 20.7. CONMED Corporation
  • 20.8. FUJIFILM Holdings Corporation
  • 20.9. GE HealthCare Technologies Inc.
  • 20.10. Hologic, Inc.
  • 20.11. KARL STORZ SE & Co. KG
  • 20.12. Koninklijke Philips N.V.
  • 20.13. Leica Microsystems GmbH
  • 20.14. Medtronic plc
  • 20.15. Mindray Medical International Limited
  • 20.16. Olympus Corporation
  • 20.17. Shimadzu Corporation
  • 20.18. Siemens Healthineers AG
  • 20.19. Smith & Nephew plc
  • 20.20. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILITY & INSTALLATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING RESOLUTION & FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL IMAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SURGICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES SURGICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA SURGICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CONTRAST AGENTS & DYES (ICG), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CONTRAST AGENTS & DYES (ICG), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CONTRAST AGENTS & DYES (ICG), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DRAPES & COVERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DRAPES & COVERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DRAPES & COVERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CABLES & CONNECTIVITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CABLES & CONNECTIVITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CABLES & CONNECTIVITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CAMERA HEADS & SCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CAMERA HEADS & SCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CAMERA HEADS & SCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DETECTORS & SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DETECTORS & SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DETECTORS & SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DISPLAYS & RECORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DISPLAYS & RECORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DISPLAYS & RECORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL IMAGING MARKET SIZE, BY LIGHT SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL IMAGING MARKET SIZE, BY LIGHT SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL IMAGING MARKET SIZE, BY LIGHT SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INSTALLATION & VALIDATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INSTALLATION & VALIDATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INSTALLATION & VALIDATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAINTENANCE & REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAINTENANCE & REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAINTENANCE & REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AI APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AI APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AI APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DOSE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DOSE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DOSE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGE PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGE PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGE PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL IMAGING MARKET SIZE, BY WORKFLOW & PACS INTEGRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL IMAGING MARKET SIZE, BY WORKFLOW & PACS INTEGRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL IMAGING MARKET SIZE, BY WORKFLOW & PACS INTEGRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STEREOTACTIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STEREOTACTIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STEREOTACTIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TOMOSYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TOMOSYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TOMOSYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CT-BASED 3D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CT-BASED 3D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CT-BASED 3D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MR-BASED 3D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MR-BASED 3D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MR-BASED 3D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOSCOPIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOSCOPIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOSCOPIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NIR/ICG FLUORESCENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NIR/ICG FLUORESCENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NIR/ICG FLUORESCENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYBRID OR SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYBRID OR SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYBRID OR SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INTRAOPERATIVE CT/O-ARM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INTRAOPERATIVE CT/O-ARM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INTRAOPERATIVE CT/O-ARM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FULL-SIZE C-ARM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FULL-SIZE C-ARM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FULL-SIZE C-ARM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MINI C-ARM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MINI C-ARM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MINI C-ARM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILITY & INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FLOOR-MOUNTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FLOOR-MOUNTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FLOOR-MOUNTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CART-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CART-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CART-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOVABLE GANTRY/SLIDING MAGNET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOVABLE GANTRY/SLIDING MAGNET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOVABLE GANTRY/SLIDING MAGNET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING RESOLUTION & FORMAT, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 4K, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 4K, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 4K, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 8K, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 8K, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 8K, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COLOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COLOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COLOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DUAL-CHANNEL VISIBLE/NIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DUAL-CHANNEL VISIBLE/NIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DUAL-CHANNEL VISIBLE/NIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HD 1080P, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HD 1080P, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HD 1080P, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MONOCHROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MONOCHROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MONOCHROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STRUCTURAL HEART, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STRUCTURAL HEART, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STRUCTURAL HEART, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENT/HEAD & NECK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENT/HEAD & NECK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENT/HEAD & NECK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENT/HEAD & NECK, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SINUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SINUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SINUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SKULL BASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SKULL BASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SKULL BASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL SURGICAL IMAGING MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL SURGICAL IMAGING MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL SURGICAL IMAGING MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL SURGICAL IMAGING MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COLORECTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COLORECTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COLORECTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HEPATOBILIARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HEPATOBILIARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HEPATOBILIARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FUNCTIONAL/DBS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FUNCTIONAL/DBS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FUNCTIONAL/DBS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TUMOR RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TUMOR RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TUMOR RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ORTHOPEDIC & TRAUMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 223. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ORTHOPEDIC & TRAUMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ORTHOPEDIC & TRAUMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ORTHOPEDIC & TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 226. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SPINE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SPINE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SPINE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. GLOBAL SURGICAL IMAGING MARKET SIZE, BY UROLOGY & GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL SURGICAL IMAGING MARKET SIZE, BY UROLOGY & GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL SURGICAL IMAGING MARKET SIZE, BY UROLOGY & GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. GLOBAL SURGICAL IMAGING MARKET SIZE, BY UROLOGY & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYSTERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 238. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYSTERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL SURGICAL IMAGING MARKET SIZE, BY PROSTATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL SURGICAL IMAGING MARKET SIZE, BY PROSTATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 241. GLOBAL SURGICAL IMAGING MARKET SIZE, BY PROSTATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL SURGICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 244. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 247. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 250. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 251. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SPECIALTY CLINICS & OFFICE-BASED LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 257. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SPECIALTY CLINICS & OFFICE-BASED LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SPECIALTY CLINICS & OFFICE-BASED LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. GLOBAL SURGICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 260. AMERICAS SURGICAL IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 261. AMERICAS SURGICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 262. AMERICAS SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 263. AMERICAS SURGICAL IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 264. AMERICAS SURGICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 265. AMERICAS SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 266. AMERICAS SURGICAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. AMERICAS SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, 2018-2032 (USD MILLION)
  • TABLE 268. AMERICAS SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, 2018-2032 (USD MILLION)
  • TABLE 269. AMERICAS SURGICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 270. AMERICAS SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 271. AMERICAS SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 272. AMERICAS SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 273. AMERICAS SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, 2018-2032 (USD MILLION)
  • TABLE 274. AMERICAS SURGICAL IMAGING MARKET SIZE, BY MOBILITY & INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 275. AMERICAS SURGICAL IMAGING MARKET SIZE, BY FIXED, 2018-2032 (USD MILLION)
  • TABLE 276. AMERICAS SURGICAL IMAGING MARKET SIZE, BY MOBILE, 2018-2032 (USD MILLION)
  • TABLE 277. AMERICAS SURGICAL IMAGING MARKET SIZE, BY IMAGING RESOLUTION & FORMAT, 2018-2032 (USD MILLION)
  • TABLE 278. AMERICAS SURGICAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. AMERICAS SURGICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 280. AMERICAS SURGICAL IMAGING MARKET SIZE, BY ENT/HEAD & NECK, 2018-2032 (USD MILLION)
  • TABLE 281. AMERICAS SURGICAL IMAGING MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 282. AMERICAS SURGICAL IMAGING MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 283. AMERICAS SURGICAL IMAGING MARKET SIZE, BY ORTHOPEDIC & TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 284. AMERICAS SURGICAL IMAGING MARKET SIZE, BY UROLOGY & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 285. AMERICAS SURGICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. AMERICAS SURGICAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 288. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 290. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 292. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, 2018-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, 2018-2032 (USD MILLION)
  • TABLE 296. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 298. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 300. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, 2018-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY MOBILITY & INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 302. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY FIXED, 2018-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY MOBILE, 2018-2032 (USD MILLION)
  • TABLE 304. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY IMAGING RESOLUTION & FORMAT, 2018-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 306. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY ENT/HEAD & NECK, 2018-2032 (USD MILLION)
  • TABLE 308. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 310. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY ORTHOPEDIC & TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 311. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY UROLOGY & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 312. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 314. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 315. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 316. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 318. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 319. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 320. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 321. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, 2018-2032 (USD MILLION)
  • TABLE 322. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, 2018-2032 (USD MILLION)
  • TABLE 323. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 324. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 325. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 326. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY FIXED C-AR